newsfilter
← Latest News
GlobeNewswire·

Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing

ZY

EMERYVILLE, Calif., March 06, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) is pleased to announce early results from its work on infectious disease, discovering hundreds of potential novel hits against malaria, tuberculosis, and COVID-1